Rating History for Atea Pharmaceuticals (AVIR) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/10/2023 | Eric Joseph | Downgrade | Underweight (Neutral) |
N/A (N/A) |
3.41 (5.89) |
72.73% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/10/2023 | Eric Joseph | Downgrade | Underweight (Neutral) |
N/A (N/A) |
3.41 (5.89) |
72.73% | Details |
![]() |
|||||||
![]() |
|||||||